Insulin action in the polycystic ovary syndrome

Endocrinology and Metabolism Clinics of North America

Volumn 28, Issue 2, 1999, Pages 341-359

  Dunaif, A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TOLERANCE; HUMAN; HYPERANDROGENISM; INSULIN RELEASE; MENSTRUATION DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0032977329     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70073-6     Document Type: Article

References (57)

1. R.N. Bergman Toward physiological understanding of glucose tolerance: Minimal model approach Diabetes 38 1989 1512 1527
2. V.A. Blakesley A. Scrimgeour D. Esposito Signaling via the insulin-like growth factor-I receptor: Does it differ from insulin receptor signaling? Cytokine & Growth Factor Reviews 7 1996 153 159
3. C.K. Buffington A.E. Kitabchi Evidence for a defect in insulin metabolism in hyperandrogenic women with polycystic ovary syndrome Metabolism 43 1994 1367 1372
4. G.A. Burghen J.R. Givens A.E. Kitabchi Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease J Clin Endocrinol Metab 50 1980 113 116
5. T.P. Ciaraldi A.J. Morales M.G. Hickman Cellular insulin resistance in adiopocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity J Clin Endocrinol Metab 82 1997 1421 1425
6. T.P. Ciaraldi A.J. Morales M.G. Hickman Lack of insulin resistance in fibroblasts from subjects with polycystic ovary syndrome Metabolism 47 1998 940 946
7. T.P. Ciaraldi A. El-Roeiy Z. Madar Cellular mechanisms of insulin resistance in polycystic ovary syndrome J Clin Endocrinol Metab 75 1992 577 583
8. E. Dahlgren S. Johansson G. Lindstedt Women with polycystic ovary syndrome wedge resected in 1956 to 1965: A long-term follow-up focusing on natural history and circulating hormones Fertil Steril 57 1992 505 513
9. R.A. DeFronzo Pathogenesis of type 2 diabetes: Metabolic and molecular implications for identifying diabetes genes Diabetes Rev 5 1997 177 269
10. A. Dunaif Insulin resistance and the polycystic ovary syndrome: Mechanisms and implications for pathogenesis Endocr Rev 18 1997 774 800
11. Dunaif A, Book C-B: Selective intrinsic defects in insulin and IGF-1 action in polycystic ovary syndrome (PCOS) in skin fibroblasts [abstract 317]. Presented at the 56th Annual Meeting of the American Diabetes Association, San Francisco, CA, June 1996
12. Dunaif A, Diamanti-Kandarakis E: Defective insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS) [abstract 91]. In Program of the 57th Annual Scientific Meeting of the American Diabetes Association, Boston, MA, June 1997
13. A. Dunaif D.T. Finegood β-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome J Clin Endocrinol Metab 81 1996 942 947
14. A. Dunaif M. Graf Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with polycystic ovary syndrome J Clin Invest 83 1989 23 29
15. A. Dunaif W. Futterweit K.R. Segal Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome Diabetes 41 1992 1257 1266
16. A. Dunaif W. Futterweit K.R. Segal Profound peripheral insulin resistance, independent of obesity, in the polycystic ovary syndrome Diabetes 38 1989 1165 1174
17. A. Dunaif J.R. Givens F. Haseltine The Polycystic Ovary Syndrome 1992 Blackwell Scientific Cambridge, MA
18. A. Dunaif M. Graf J. Mandeli Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance and/or hyperinsulinemia J Clin Endocrinol Metab 65 1987 499 507
19. A. Dunaif G. Green W. Futterweit Supression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome J Clin Endocrinol Metab 70 1990 699 704
20. A. Dunaif D. Scott D. Finegood The insulin sensitizing agent troglitazone: A novel therapy for the polycystic ovary syndrome J Clin Endocrinol Metab 81 1996 3299 3306
21. A. Dunaif J. Xia Book C.-B. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle: A potential mechanism for insulin resistance in the polycystic ovary syndrome J Clin Invest 96 1995 801 810
22. D.A. Ehrmann J. Sturis N.M. Byrne Insulin secretory defects in polycystic ovary syndrome: Relationship to insulin sensitivity and family history of non–insulin-dependent diabetes mellitus J Clin Invest 96 1995 520 527
23. I. Ek P. Arner A. Bergqvist Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: A possible link to insulin resistance? J Clin Endocrinol Metab 82 1997 1147 1153
24. K.E. Elkind-Hirsh C.T. Vales L.R. Malinak Insulin resistance improves in hyperandrogenic women treated with Lupron Fertil Steril 60 1993 634 641
25. S. Gasic Y. Bodenburg M. Nagamani Troglitazone inhibits progesterone production in porcine granulosa cells Endocrinology 139 1998 4692 1696
26. J. Holte T. Bergh C. Berne Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance J Clin Endocrinol Metab 78 1994 1052 1058
27. J. Holte T. Bergh C. Berne Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome J Clin Endocrinol Metab 80 1995 2586 2593
28. A.H. Kissebah A.N. Peiris Biology of regional body fat distribution: Relationship to non–insulin-dependent diabetes mellitus Diabetes Metab Rev 5 1989 83 109
29. E.S. Knochenhauser T.J. Key M. Kahsar-Miller Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study J Clin Endocrinol Metab 83 1998 3078 3082
30. R.S. Legro D. Driscoll J.F. Strauss Evidence for a genetic basis for hyperandrogenemia in the polycystic ovary syndrome Proc Natl Acad Sci USA 95 1998 14956 14960
31. Legro RS, Kunselman A, Dodson WC, et al: Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women. J Clin Endocrinol Metab, in press
32. R.S. Legro R. Spielman M. Urbanek Phenotype and genotype in polycystic ovary syndrome Recent Prog Horm Res 53 1998 217 256
33. B.A. Maddux P. Sbraccia S. Kumakura Membrane glycoprotein PC-1 and insulin resistance in non–insulin-dependent diabetes mellitus Nature 373 1995 448 451
34. P.J. Marsden A. Murdoch R. Taylor Severe impairment of insulin action in adipocytes from amenorrheic subjects with polycystic ovary syndrome Metabolism 43 1994 1536 1542
35. P. Moghetti R. Castello C. Negri Insulin infusion amplifies 17 α-hydroxycorticosteroid intermediate response to adrenocorticotropin in hyperandrogenic women: Apparent relative impairment of 17,20-lyase activity J Clin Endocrinol Metab 81 1996 881 886
36. P. Moghetti F. Tosi R. Castello The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: Evidence that androgens impair insulin action in women J Clin Endocrinol Metab 81 1996 952 960
37. J.E. Nestler Sex hormone–binding globulin: A marker for hyperinsulinemia and/or insulin resistance? J Clin Endocrinol Metab 76 1993 273 274
38. J.E. Nestler D.J. Jakubowicz Decreases in ovarian cytochrome P450c17α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome N Engl J Med 335 1996 617 623
39. J.E. Nestler C.O. Barlascini D.W. Matt Suppression of serum insulin by diazoxide reduced serum testosterone levels in obese women with polycystic ovary syndrome J Clin Endocrinol Metab 68 1989 1027
40. J.E. Nestler D.J. Jakobowicz De Vargas A.F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system J Clin Endocrinol Metab 83 1998 2001 2005
41. J.E. Nestler D.J. Jakubowicz W.S. Evans Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome N Engl J Med 338 1998 1876 1880
42. J.E. Nestler R. Singh D.W. Matt Suppression of serum insulin levels by diazoxide does not alter serum testosterone or sex hormone-binding globulin levels in healthy, nonobese women Am J Obstet Gynecol 163 1990 1243 1246
43. N.M. O'Meara J.D. Blackman D.A. Ehrmann Defects in β-cell function in functional ovarian hyperandrogenism J Clin Endocrinol Metab 76 1993 1241 1247
44. T.S. Pillay S. Xiao J.M. Olefsky Glucose-induced phosphorylation of the insulin receptor J Clin Invest 97 1996 613 620
45. K.H. Polderman J.G. Gooren H. Asscherman Induction of insulin resistance by androgens and estrogens J Clin Endocrinol Metab 79 1994 265 271
46. D.W. Polson J. Wadsworth J. Adams Polycystic ovaries—a common finding in normal women Lancet 1 1988 870 872
47. J. Rincon A. Holmang E.O. Wahlstrom Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment Diabetes 45 1996 615 621
48. S. Robinson J. Kiddy S.V. Gelding The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries Clin Endocrinol (Oxf) 39 1993 351 355
49. D. Rosenbaum R. Haber A. Dunaif Insulin resistance in polycystic ovary syndrome: Decreased expression of GLUT4 glucose transporters in adipocytes Am J Physiol 264 1993 E197 E202
50. A.R. Saltiel Diverse signaling pathways in the cellular actions of insulin Am J Physiol 270 1996 E375 E385
51. L.R. Sorbara Z. Tang A. Cama Absence of insulin receptor gene mutations in three women with the polycystic ovary syndrome Metabolism 43 1994 1568 1574
52. D.M. Waterworth S.T. Bennett N. Gharani Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome Lancet 349 1997 986 990
53. M.F. White The IRS-signaling system: A network of docking proteins that mediate insulin and cytokine action [in process citation] Recent Prog Horm Res 53 1998 119 138
54. M.F. White L. Yenush The IRS-signaling system: A network of docking proteins that mediate insulin and cytokine action Curr Top Microbiol Immunol 228 1998 179 208
55. D. Willis S. Franks Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-1 insulin-like growth factor receptor J Clin Endocrinol Metab 80 1995 3788 3790
56. D.J. Withers J.S. Gutierrez H. Towery Disruption of IRS-2 causes type 2 diabetes in mice Nature 391 1998 900 904
57. L. Zhang H. Rodriquez S. Ohno Serine phosphorylation of human P450c17 increases 17,20 lyase activity: Implications for adrenarche and the polycystic ovary syndrome Proc Natl Acad Sci USA 92 1995 10619 10623